EA200702282A1 - Комбинация феррохина и производного артемизинина для лечения малярии - Google Patents

Комбинация феррохина и производного артемизинина для лечения малярии

Info

Publication number
EA200702282A1
EA200702282A1 EA200702282A EA200702282A EA200702282A1 EA 200702282 A1 EA200702282 A1 EA 200702282A1 EA 200702282 A EA200702282 A EA 200702282A EA 200702282 A EA200702282 A EA 200702282A EA 200702282 A1 EA200702282 A1 EA 200702282A1
Authority
EA
Eurasian Patent Office
Prior art keywords
derivative
malaria
combination
treatment
relates
Prior art date
Application number
EA200702282A
Other languages
English (en)
Other versions
EA012630B1 (ru
Inventor
Лоран Фрэсс
Даниэль Тер-Минассян
Original Assignee
Санофи-Авентис
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Санофи-Авентис filed Critical Санофи-Авентис
Publication of EA200702282A1 publication Critical patent/EA200702282A1/ru
Publication of EA012630B1 publication Critical patent/EA012630B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Изобретение относится к комбинации, содержащей феррохин в виде свободного основания, соли, гидрата или сольвата и производное артемизинина. Изобретение относится также к фармацевтической композиции, содержащей феррохин в виде одной из его фармацевтически приемлемых солей, гидрата или сольвата и по меньшей мере одно производное артемизинина. Изобретение относится также к применению такой комбинации для получения лекарственного средства, предназначенного для лечения или профилактики малярии. Изобретение относится также к набору для лечения или профилактики малярии.
EA200702282A 2005-04-20 2006-04-18 Комбинация феррохина и производного артемизинина для лечения малярии EA012630B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0503932A FR2884715B1 (fr) 2005-04-20 2005-04-20 Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme
PCT/FR2006/000842 WO2006111647A1 (fr) 2005-04-20 2006-04-18 Association entre la ferroquine et un derive d’artemisinine pour le traitement du paludisme

Publications (2)

Publication Number Publication Date
EA200702282A1 true EA200702282A1 (ru) 2008-02-28
EA012630B1 EA012630B1 (ru) 2009-10-30

Family

ID=35385843

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200702282A EA012630B1 (ru) 2005-04-20 2006-04-18 Комбинация феррохина и производного артемизинина для лечения малярии

Country Status (30)

Country Link
US (1) US20120258945A1 (ru)
EP (1) EP1874293A1 (ru)
JP (1) JP5148478B2 (ru)
KR (1) KR20080009088A (ru)
CN (2) CN102836163A (ru)
AP (1) AP2782A (ru)
AR (1) AR054253A1 (ru)
AU (1) AU2006238506B2 (ru)
BR (1) BRPI0610851A2 (ru)
CA (1) CA2605385A1 (ru)
CR (1) CR9425A (ru)
DO (1) DOP2006000092A (ru)
EA (1) EA012630B1 (ru)
FR (1) FR2884715B1 (ru)
GT (1) GT200600157A (ru)
HN (1) HN2006015130A (ru)
IL (1) IL186048A0 (ru)
MA (1) MA29451B1 (ru)
MX (1) MX2007012645A (ru)
MY (1) MY145581A (ru)
NO (1) NO20075920L (ru)
NZ (1) NZ562117A (ru)
PA (1) PA8669801A1 (ru)
PE (2) PE20061314A1 (ru)
SG (1) SG161270A1 (ru)
TN (1) TNSN07359A1 (ru)
TW (1) TWI387456B (ru)
UA (1) UA96414C2 (ru)
WO (1) WO2006111647A1 (ru)
ZA (1) ZA200708800B (ru)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926993B1 (fr) * 2008-02-06 2011-03-11 Sanofi Aventis Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme
FR2952823B1 (fr) * 2009-10-30 2012-04-20 Sanofi Aventis Utilisation de la ferroquine dans le traitement ou la prevention du paludisme
FR2951945B1 (fr) 2009-11-05 2013-08-09 Sanofi Aventis Composition pharmaceutique
FR2961209B1 (fr) * 2010-06-11 2013-03-01 Sanofi Aventis Procede de synthese de la ferroquine par amination reductrice convergente.
FR2989588A1 (fr) * 2012-04-19 2013-10-25 Centre Nat Rech Scient Composes pour la prevention ou le traitement des infections par des virus de la famille des flaviviridae
MX2016005959A (es) 2013-11-08 2016-10-14 Exthera Medical Corp Métodos para diagnosticar enfermedades infecciosas usando medio de adsorción.
CN105250295B (zh) * 2014-07-07 2018-12-25 广州中医药大学科技产业园有限公司 一种联合用药物及其作为免疫调节剂的应用
WO2017015344A1 (en) * 2015-07-20 2017-01-26 University Of Vermont And State Agricultural College Use of cymanquine compounds as antimalarial agents
CN107802755A (zh) * 2017-11-08 2018-03-16 江西龙卿堂科技有限公司 一种具有防蚊防疟作用的青蒿软膏
KR102073961B1 (ko) * 2018-11-16 2020-02-05 (주)프론트바이오 메트포르민 및 페로센계 화합물을 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물
WO2022231238A1 (ko) * 2021-04-26 2022-11-03 심민보 아르테수네이트 또는 그의 염, 및 피로나리딘 또는 그의 염의 해열, 항염증, 항바이러스용, 또는 covid-19 예방 또는 치료용 약학적 조성물 및 이를 이용한 방법
CN113952360B (zh) * 2021-09-14 2023-03-10 上海交通大学 一种亚铁离子在治疗疟疾的药物中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN166154B (ru) * 1987-05-08 1990-03-24 Hoechst India
ZA200602031B (en) * 2003-09-04 2007-05-30 Cipla Ltd Antimalarial compositions and process thereof

Also Published As

Publication number Publication date
MX2007012645A (es) 2007-12-13
FR2884715A1 (fr) 2006-10-27
EA012630B1 (ru) 2009-10-30
PE20061314A1 (es) 2006-12-27
JP5148478B2 (ja) 2013-02-20
CN101163470A (zh) 2008-04-16
MY145581A (en) 2012-02-29
TW200716092A (en) 2007-05-01
PA8669801A1 (es) 2006-11-09
TWI387456B (zh) 2013-03-01
US20120258945A1 (en) 2012-10-11
NO20075920L (no) 2007-11-16
DOP2006000092A (es) 2006-11-15
NZ562117A (en) 2010-01-29
CA2605385A1 (fr) 2006-10-26
EP1874293A1 (fr) 2008-01-09
FR2884715B1 (fr) 2007-06-15
ZA200708800B (en) 2009-01-28
AR054253A1 (es) 2007-06-13
WO2006111647A1 (fr) 2006-10-26
AU2006238506B2 (en) 2012-03-01
JP2008536900A (ja) 2008-09-11
CN102836163A (zh) 2012-12-26
BRPI0610851A2 (pt) 2010-08-03
UA96414C2 (ru) 2011-11-10
HN2006015130A (es) 2010-08-19
PE20110119A1 (es) 2011-03-08
AU2006238506A1 (en) 2006-10-26
CR9425A (es) 2008-02-20
TNSN07359A1 (en) 2008-12-31
AP2782A (en) 2013-10-31
AP2007004211A0 (en) 2007-10-31
SG161270A1 (en) 2010-05-27
KR20080009088A (ko) 2008-01-24
GT200600157A (es) 2006-11-07
IL186048A0 (en) 2008-02-09
MA29451B1 (fr) 2008-05-02

Similar Documents

Publication Publication Date Title
EA200702282A1 (ru) Комбинация феррохина и производного артемизинина для лечения малярии
NO2023022I1 (no) cobimetinib, optionally in any form protected by the basic patent, including harmaceutically acceptable salts and sovates thereof, particularly cobimetinib hemifumarate
UA92000C2 (en) 1-benzylindole-2-carboxamide derivatives
EA200701357A1 (ru) Композиции и способы применения модулятора рецептора 5ht
EA200802118A1 (ru) Обладающие ингибирующей активностью в отношении mnk1/mnk2 тиенопиримидины, предназначенные для применения в фармацевтических композициях
ECSP088902A (es) Derivados de pirazolo[3,4-d]-pirimidina utiles para tratar trastornos respiratorios
TW200722081A (en) New therapeutic combinations for the treatment or prevention of depression
EA200802390A1 (ru) Конъюгаты аналогов азиридилэпотилона и фармацевтические композиции, содержащие их
EA200970935A1 (ru) Способы лечения с применением хинаксолиновых ингибиторов pi3k-альфа
GEP20084439B (en) Nitrogen-containing heterocyclic derivatives and pharmaceutical use thereof
EA200970932A1 (ru) Способы лечения с применением пиридопиримидиноновых ингибиторов pi3k альфа
TW200734334A (en) Treatment of substance abuse
MX2007004248A (es) Derivados heterociclicos de bisarilurea sustituidos como inhibidores de cinasa.
GB0112348D0 (en) Compounds
EP2620145A3 (en) 2,5-dihydroxybenzene compounds for the treatment of of cancer of an organ
ATE554084T1 (de) N-hydroxyacrylamidverbindungen
UA93709C2 (ru) 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций
BRPI0816798A2 (pt) composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação
DK1784173T3 (da) Farmaceutisk sammensætning til forebyggelse og behandling af metaboliske knoglesygdomme indeholdende alpha-arylmethoxyacrylatderivater
EA201171229A1 (ru) Терапевтическое применение производных хиназолиндиона при сердечно-сосудистых заболеваниях
WO2006097472A3 (en) Novel inhibitors of glutathione-s-transferase
ATE496899T1 (de) Tetrahydro- und dihydrochinazolinone
CY1111067T1 (el) Χρηση της ν-(διβενζ (β,f) οξεπιν-10-υλμεθυλ) -ν-μεθυλ-ν-προπ-2-υνυλαμινης (omigapil) στην προληψη και/ή την θεραπεια της μυϊκης δυστροφiας
EA200802000A1 (ru) Фармацевтически приемлемые соли и полиморфные формы
MXPA06002778A (es) Combinacion de inhibidores de recaptacion de serotonina e inhibidores de recaptacion de norepinefrina.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU